跳至主要内容
临床试验/ISRCTN73579020
ISRCTN73579020已完成2 期

Randomised placebo-controlled, double-blind, exploratory trial of Bosentan for Steroid-resistant Pulmonary Sarcoidosis: the BOSSA Study

niversity Hospital Basel (Switzerland)0 个研究点目标入组 36 人开始时间: 2010年9月27日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Biopsy-proven sarcoidosis with pulmonary involvement stages II, III, (IV) according to Silzbach
  • 2. Persistant symptoms on long-term oral corticosteroids (greater than 2 months; 5 mg prednisone or equivalent and/or other immunosuppressive agents
  • 3. Aged greater than 18 years
  • 4. Informed written consent
  • 5. Impaired exercise capacity (oxygen uptake [VO2] peak less than 80%) or resting lung functions (forced expiratory volume in one second [FEV1], forced vital capacity [FVC] or diffusing capacity of the lung for carbon monoxide [DLCO] less than 80%)

排除标准

  • 1. Systemic illness other than sarcoidosis requiring immunosuppressive therapy
  • 2. Honey combing greater than 10% on High Resolution Computed Tomography [HRCT] scan
  • 3. Marked disturbance of liver enzymes at baseline
  • 4. Pregnancy
  • 5. Relevant psychiatric illness or addictive disorder
  • 6. Previous or current treatment with bosentan
  • 7. Therapry with cyclosporine A

研究者

发起方
niversity Hospital Basel (Switzerland)

相似试验